Where it is registered
Each register with its number of medicines and a few of them.
Saudi Arabia
SFDA · 1 medicine · Historical list
All medicines with Haemophilus influenza conjugate
Every register, a page at a time. Strengths and packs are on each medicine’s page.
17 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Vacina Haemophilus Influenzae B (Conjugada) | Brazil | Authorised | Fundação Oswaldo Cruz | ||
| Synflorix VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Infanrix Hexa | European Union | Authorised | GlaxoSmithKline Biologicals S.A. | ||
| Hexyon | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Hexacima | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Vaxelis | European Union | Authorised | MCM Vaccine B.V. | ||
| Infanrix-Ipv/HibCombination | Canada | 30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| vacina Haemophilus influenzae b (conjugada) | Brazil | Cancelled | Glaxosmithkline Brasil Ltda | ||
| Vacina Haemophilus Influenzae B (Conjugada) | Brazil | Cancelled | Sanofi-Aventis Farmacêutica Ltda | ||
| Vacina Haemophilus Influenzae B (Conjugada) | Brazil | Cancelled | Sanofi Medley Farmacêutica Ltda. | ||
| Synflorix Suspension for Injection (Prefilled Syringe)Combination | Singapore | 1 μg PS1; 1.11-1.67 μg PD/dose + 1 μg PS14; 1.00-1.82 μg PD/dose + 3 μg PS18C; 5.45-10.00 μg TT/dose + 3 μg PS19F; 3.33-6.00 μg DT/dose + 1 μg PS23F; 0.39-0.74 μg PD/dose + 3 μg PS4; 3.33-6.67 μg PD/dose + 1 μg PS5; 0.67-1.25 μg PD/dose + 1 μg PS6B; 0.56-0.95 μg PD/dose + 1 μg PS7F; 0.87-1.43 μg PD/dose + 1 μg PS9V; 1.00-1.82 μg PD/dose + 3-6 μg DT/dose (total DT content) + 16 μg/dose (total PS content) + 9-16 μg PD/dose (total PD content) + 5-10 μg/dose | injection, suspension | Authorised | Glaxosmithkline Pte LTD |
| Hexaxim Suspension for Injection in Pre-Filled SyringeCombination | Singapore | 30 Lf (>= 20 IU)/0.5 mL + 25 μg/0.5 mL + 12 μg/0.5 mL + 10 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + 10 Lf (>= 40 IU)/0.5 mL | injection, suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Pentaxim VaccineCombination | Singapore | min. 20 IU (30 Lf)/0.5 mL + 25 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + min. 40 IU (10 Lf) /0.5 mL + 10 μg/0.5 mL + 18 - 30 μg/0.5 mL | injection, powder, for suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Vacina conjugada contra Haemophilus influenzae tipo B | Brazil | Cancelled | Organon Farmacêutica Ltda. | ||
| Hexavac | European Union | Withdrawn | Sanofi Pasteur MSD, SNC | ||
| Quintanrix | European Union | Withdrawn | GlaxoSmithKline Biologicals S.A. | ||
| Hiberix | Canada | 10 MCG / 0.5 ML | Powder For Solution | Cancelled | Glaxosmithkline INC |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Sources
Compiled by Prognia from the public medicine registers of SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 1
- Companies
- 1